Navigation Links
Enzyme for treatment of arthritis

Scientists have identified an enzyme’s new role in aiding joint inflammations in conditions like // arthritis.

An enzyme called cathepsin G can regulate the ability of the immune cells to secrete chemicals that will start the process of inflammatory conditions that can lead to arthritis. The enzyme cathepsin G attracts accumulation of immune cells that can lead to damage of the tissue and cartilage in joints leading to the inflammatory condition of arthritis.

Researchers of the study feel that the enzyme can be targeted for the treatment of arthritis as it is involved in the very initial stages of the arthritis condition and hence may bring long-term relief.

Cathepsin G enzyme is part of a group pf enzymes called proteases. Proteases are the enzymes that are targeted when treating HIV patients in one of the treatment procedures. In targeting the enzyme for arthritis treatment, scientists may already have a lot of research updates available on the protein that can be used to discover new ways of relieving people suffering from the pains of arthritis.

The researchers did the research from Washington University School of Medicine in St. Louis.

Reference: Immunity, June 200
'"/>




Page: 1

Related medicine news :

1. Enzyme may be target for obesity drugs
2. Researchers trick Alzheimers Enzyme
3. Enzyme stimulates growth of adult stem cells
4. Enzyme may aid hold back disease
5. Enzyme help destroy cancer cell
6. Enzyme Associated with Memory
7. Enzyme Associated With Memory
8. Brain Enzyme Found To Regulate Weight
9. New Enzyme Identified For Arthritis
10. An Enzyme That Turns a One –time Experience into a long-time Memor
11. Enzyme Responsible For Congenital Blindness

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Enzyme for treatment arthritis

(Date:11/25/2009)..., DELMAR,Calif.,Nov.25()/PRNewswire-FirstCall/-...ldings Corporation(PinkSheets:ADHC),announcedtoday...tionsplatform,enablinginvestorstoeasilyaccesstimel...ewsystemcanbeaccessedat: http://www.americandivers...isimportantandournewwebsiteallowsustoprovidereleva...
(Date:11/25/2009)...ditional South American medicinal herb proves effe.... 25 (HealthDay News) -- An herb called Brazilian ...drugs, English researchers report. , Traditiona...s crenata to treat a range of health problems, in...is study is the first to scientifically prove the ...
(Date:11/25/2009)..., SANFRANCISCO,Nov.25/PRNewswire/--IntroducingP...colorcosmeticsandadvancedskincarededicatedtoprovid...iBeautyisthefirstprestigeskincareandcolorcosmeticb...tistryStores,withofficesinSanFranciscoandToronto,w...ailprofessionalswithover35yearsexperienceintheindu...
(Date:11/25/2009)... Dr. Neil J. Zemmel, a board...hing a new website utilizing the latest internet t...t and breast reconstruction procedures. The new si...eate an interactive web experience that’s de...ual tour of Dr. Zemmel’s practice. , ...
(Date:11/25/2009)... The American Society of Hem...rsquo;s publishing, education, and media company, ...” a dynamic science curriculum designed to s...e, in addition to exposing students to exciting ca... Washington (PRWEB) November 25, 2009 --...
Breaking Medicine News(10 mins):Health News:American Diversified Holdings Corporation Announces New Website 2Health News:Pari Beauty Professional Artistry 2Health News:Richmond, Virginia Plastic Surgeon Launches State-of-the-Art Breast Surgery Website 2Health News:Richmond, Virginia Plastic Surgeon Launches State-of-the-Art Breast Surgery Website 3Health News:Richmond, Virginia Plastic Surgeon Launches State-of-the-Art Breast Surgery Website 4Health News:New Science Program Teaches High School Students About Blood and Career Opportunities in the Field of Hematology 2Health News:New Science Program Teaches High School Students About Blood and Career Opportunities in the Field of Hematology 3
...en just once per month, experts say , FRIDAY, Oct....g anemia in patients with severe kidney disease co...ing to a U.S. study. , Compared with conventional ...l Research Institute in New York, and colleagues. ...
...thopedic Institute of Chicago Offer Complimentary ...linical Study., CHICAGO, Oct. 19 , What: ... Stage IV breast cancer are eligib...ve for a protein called human epid...
...18 The following statement,is attributable to: Ro...Medical Association (AMA) welcomes today,s decisio...to issue a consumer warning,about the potentially ...med purchasers of health care. Achieving this goal...
...if., Oct. 18 The annual HMO,report card released ...ague,and incomplete that it does not allow consume...he report omits key consumer information including...CR)., FTCR noted that today,s release was timed t...
...18 The Association of,American Physicians and Sur...Serkes, director of policy and public affairs, in ...today to override President Bush,s veto,of a bill ...would,have spent almost as much money on doctors a...
...f., Oct. 18 Align,Technology, Inc. (Nasdaq: ALGN...od of straightening teeth without wires or bracket...ation Program by the Academy of General,Dentistry,... implementing continuing education. It was created...
Other Medicine News:Health News:Simpler Anemia Treatment May Help Kidney Patients 2Health News:Brain Screenings Offered to Breast Cancer Patients During Breast Cancer Awareness Month 2Health News:State's HMO 'Report Card' Fails in Meaningful Evaluation of Health Care Quality and Ignores Affordability 2Health News:State's HMO 'Report Card' Fails in Meaningful Evaluation of Health Care Quality and Ignores Affordability 3Health News:Doctors Applaud SCHIP Veto: Bill Supports Special Interests, Not Kids; Almost Half of Funds Go to Doctors & Seniors 2Health News:Align Technology, Inc. Earns PACE Approval From Academy of General Dentistry 2Health News:Align Technology, Inc. Earns PACE Approval From Academy of General Dentistry 3
(Date:11/25/2009)...dsandJOHANNESBURG,November25/PRNewswire/--,iThemba...nouncedtoday,thattheyhavesignedacollaborativeagree... Pyxis,sworldclasscomputationalchemistryandleaddis...ivisiontoprovidemedicinaland,syntheticchemistrysup...lclientnetwork.iThembaPharmaceuticalsandPyxisDisco...
(Date:11/25/2009)....,Nov.25/PRNewswire/-- ChemoCentryx,Inc.,announce...ROTECT-1(theProspectiveRandomizedOralTherapyEvalua...-B)inpatientswithmoderate-to-severeCrohn,sdiseased...tolerabilityprofile.Thestudydemonstratedevidenceof...efinedasa70-pointdecreaseintheCrohn,sDiseaseActivi...
(Date:11/24/2009)...PRNewswire/-- ,, WHAT:RomHoubens,aBelgianmantho...ent,wasactuallyfullyconsciousandawakeduringthattim...ynaVoxEyeMaxwasfeaturedinthesegmenttoillustratehow...lockcommunication. ,, WHEN:GoodMorningAmerica--...oxtech.com ,, WHO:RomHoubenswasanengineerin...
Breaking Medicine Technology:iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2Emdeon Acquires eRx Network LLC 50665 1Emdeon Acquires eRx Network LLC 50665 2Emdeon Acquires eRx Network LLC 50665 3New Drug Could Work Against Leukemia 50663 1Sexist jokes favor the mental mechanisms that justify violence against women 50661 1Sexist jokes favor the mental mechanisms that justify violence against women 50661 2
...cals, a division of Wyeth (NYSE: WYE ), announced...(FDA) has issued an approvable letter for,the firs... the treatment of,adult patients with community-ac..., the FDA requested that Wyeth provide,additional ...ACIL for the,treatment of patients with CAP with i...
...val Benefit in Complete and Partial Respo...HEIGHTS, N.J., May 29 Genta,Incorporated (OTC Bul...erm,followup from a Phase 3 trial of the Company,s...dium) Injection, in patients with chronic,lymphocy...data show that,patients who achieved either a comp...
Other Medicine Technology:Wyeth Receives Approvable Letter from FDA for TYGACIL for the Treatment of Patients with Community-Acquired Pneumonia 2Wyeth Receives Approvable Letter from FDA for TYGACIL for the Treatment of Patients with Community-Acquired Pneumonia 3Wyeth Receives Approvable Letter from FDA for TYGACIL for the Treatment of Patients with Community-Acquired Pneumonia 4Wyeth Receives Approvable Letter from FDA for TYGACIL for the Treatment of Patients with Community-Acquired Pneumonia 5Wyeth Receives Approvable Letter from FDA for TYGACIL for the Treatment of Patients with Community-Acquired Pneumonia 6Long-Term Followup in Phase 3 CLL Trial Shows Genasense(R) is Associated with Significantly Increased Survival in All Responders 2Long-Term Followup in Phase 3 CLL Trial Shows Genasense(R) is Associated with Significantly Increased Survival in All Responders 3Long-Term Followup in Phase 3 CLL Trial Shows Genasense(R) is Associated with Significantly Increased Survival in All Responders 4
O.R. Special Procedure Apron
Special Procedure Apron
Easy Wrap Apron
Disposable Monopolar NeedleElectrodes With Detachable Lead Wire
Medicine Products: